New Key Statistics Module, Z-Score and F-Score
NAS:TGTX Key Ratios
| Market Cap $ M | 2,449.51 |
| Enterprise Value $ M | 2,004.34 |
| P/E(ttm) | 1,588.00 |
| PE Ratio without NRI | 1,588.00 |
| Forward PE Ratio | 159.26 |
| Price/Book | 14.98 |
| Price/Sales | 10.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 233.00 |
| EPS (TTM) $ | 0.01 |
| Beneish M-Score | 71.93 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 78.18 |
| EV-to-EBITDA | 76.91 |
| PEG | -- |
| Shares Outstanding M | 154.54 |
| Net Margin (%) | 5.42 |
| Operating Margin % | 8.83 |
| Pre-tax Margin (%) | 5.59 |
| Quick Ratio | 5.18 |
| Current Ratio | 5.92 |
| ROA % (ttm) | 4.98 |
| ROE % (ttm) | 14.03 |
| ROIC % (ttm) | 34.38 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.99 |
TGTX Number of Guru Trades
TGTX Volume of Guru Trades
Gurus Latest Trades with NAS:TGTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TGTX is held by these investors
Total 2
TG Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TGTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers